Target intelligence / Profile preview

ribosomal protein L12 pseudogene 15 (RPL12P15)

Target
RPL12P15
Molecular classification
Pseudogene, Other
01

Overview

Ribosomal protein L12 pseudogene 15 (RPL12P15) is a processed pseudogene located within the human genome. Pseudogenes are nonfunctional sequences that resemble protein-coding genes but typically lack regulatory elements or harbor disabling mutations that prevent their expression as functional proteins. RPL12P15 is derived from the functional ribosomal protein L12 gene, which is a component of the large (60S) subunit of cytoplasmic ribosomes. Pseudogenes like RPL12P15 do not contribute to ribosomal structure or function, are not expressed as protein, and have no identified role in disease or as a therapeutic target[1][3][2][6]. Their existence is generally considered an outcome of gene duplication events or retrotransposition. RPL12P15 is frequently referenced in genomic studies for annotation purposes but has no established biological or clinical significance. Key note: If you intended the functional ribosomal protein L12 (RPL12)—not the pseudogene—see "60S ribosomal protein L12," which is an essential structural protein involved in ribosome-mediated protein synthesis[1][3]. The pseudogene (RPL12P15) is fundamentally different and is not a drug target or functionally relevant gene in current biomedical research or therapy.

Other names
ribosomal protein L12 pseudogene 15RPL12P15
02

Mechanism of action

None

03

Biological functions

Not applicable
04

Disease associations

Other
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on ribosomal protein L12 pseudogene 15 (RPL12P15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L12 pseudogene 15 (RPL12P15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call